bad termination is out of question, longer it takes for DMC better the results would be. imagine, remaining events are going to occur regardless, it is DMC's and FDA's responsibility to stop the trial if it futile to save lives, also stop the trial if its PFS is met and much superior so that lives can be saved of those in cohort.
News 
Market Data 
Discover 
